Renovaro Inc. - Common Stock (NQ: RENB )
0.6499
+0.0199
(+3.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 21, 2024
Add to My Watchlist
Press Releases about Renovaro Inc. - Common Stock![]()
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024
From Renovaro Inc
Via GlobeNewswire
Impressive Short Squeeze Triggered for Cancer Immunotherapy Company Renovaro, Inc. (NASDAQ: RENB)
June 10, 2024
Via Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![]() ![]() ![]() ![]() ![]() ![]() Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Patients with Swelling Disorder See New Gene Therapy as Godsend
February 07, 2024
![]() Via GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
January 16, 2024
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Penticton Herald
Phone number: 250-492-4002
E-mail: csr@ok.bc.ca
Address: 186 Nanaimo Ave. W.
Penticton, BC V2A 1N4
© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.